|
Market Closed -
Nasdaq
16:00:00 2026-08-19 EDT
|
5-day change | 1st Jan Change | ||
| 2.230 USD | +9.85% |
|
+7.73% | +62.77% |
| 08-13 | Allogene Therapeutics Remains Attractive Given Valuation, Clinical Strategy, RBC Says | MT |
| 08-12 | Allogene Therapeutics, Inc., Q2 2026 Earnings Call, Aug 12, 2026 |
Transcripts
Search
No results match your criteria
Select your edition
All financial news and data tailored to specific country editions
















